Pharma’s ‘come-to-Jesus moment’: The industry braces for a Pelosi speakership and Democrats’ drug pricing agenda
(By Lev Facher for STAT) WASHINGTON — Nancy Pelosi marched into PhRMA’s offices this July with the law on her
Read More(By Lev Facher for STAT) WASHINGTON — Nancy Pelosi marched into PhRMA’s offices this July with the law on her
Read More(By Kelly Gooch for Becker’s Hospital Review) Many families have delayed care due to affordability and are concerned about their
Read MoreAccording to a recent survey from the National Alliance of Healthcare Purchaser Coalitions, 60 percent of employers don’t capitalize on
Read MoreThe Centers for Medicare and Medicaid Services (CMS) says the new drug pricing model with international component could save Medicare
Read MoreAccording the a HealthView Services’ report, it found that 69 percent of adults aged 65 and older believed they’d need
Read More(By Barbara Feder Ostrov for Kaiser Health News) Janet Winston had a rash that wouldn’t go away. The English professor
Read More(By Morgan Haefner for Becker’s Hospital Review) Overall healthcare prices in Anchorage, Alaska and San Jose, Calif., are 65 percent
Read More(Source – aspe.hhs.gov) The prices charged by drug manufacturers to wholesalers and distributors (commonly referred to as exmanufacturers prices) in
Read More(By Kelly Gooch for Becker’s Hospital Review) Hospital-acquired conditions, such as air embolism, falls and trauma, and vascular catheter-associated infection,
Read More(By Megan Thielking for STAT) Crowdfunding campaigns have raked in millions of dollars for scientifically unproven — and potentially dangerous
Read More